Moreover, the ghrelin signalling pathway may represent novel therapeutic opportunities for obesity-associated inflammatory diseases including diabetes and cancers due to the anti-inflammatory properties of various ghrelin gene products23,24. The gene discussed is GHRL; the disease is obesity due to melanocortin 4 receptor deficiency.